MolDX: Molecular Testing for Solid Organ Allograft Rejection; Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection - Effective July 4, 2021

This Local Coverage Determination (LCD) has completed the Open Public Meeting comment period and is now finalized under contractor numbers: 02101 (AK), 03101 (AZ), 02201 (ID), 03201 (MT), 03301 (ND), 02301 (OR), 03401 (SD), 03501 (UT), 02401 (WA), and 03601 (WY).

Medicare Coverage Database Number LCD Title
L38671 MolDX: Molecular Testing for Solid Organ Allograft Rejection

 

Medicare Coverage Database Number Billing and Coding Article
A58170 Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection

 

Effective Date: July 4, 2021
Summary: Limited coverage for molecular diagnostic tests used in the evaluation and management of patients who have undergone solid organ transplantation. These tests can inform decision making along with standard clinical assessments in their evaluation of organ injury for active rejection (AR).

Visit the Future LCDs webpage to access this LCD.

 

            Last Updated Wed, 26 May 2021 20:03:31 +0000